IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

GSK plc

Q2 2026 Holdings

Filed 2026-08-13 | 13 holdings | $602.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$175.7M3,220,62729.2%
Wave Life Sciences LTD(WVE)SHSY95308105$106.0M18,245,69117.6%
VIR Biotechnology Inc(VIR)COM92764N102$87.1M8,550,95414.5%
Biontech SE(BNTX)SPONSORED ADS09075V102$82.8M889,82413.7%
Ideaya Biosciences Inc(IDYA)COM45166A102$49.7M1,333,3338.3%
Cytokinetics Inc(CYTK)COM NEW23282W605$29.0M340,4344.8%
Lyell Immunopharma Inc(LYEL)COM NEW55083R203$21.3M1,512,6593.5%
Spero Therapeutics Inc(SPRO)COM84833T103$20.3M9,190,6063.4%
Nkarta Inc(NKTX)COM65487U108$8.9M3,150,7321.5%
Fulcrum Therapeutics Inc(FULC)COM359616109$6.5M1,785,7141.1%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$6.5M1,529,5611.1%
Cvrx Inc(CVRX)COM126638105$5.2M1,007,5830.9%
Regenxbio Inc(RGNX)COM75901B107$3.3M271,4560.5%